106 related articles for article (PubMed ID: 17692845)
1. Heregulin-induced epigenetic regulation of the utrophin-A promoter.
Basu U; Gyrd-Hansen M; Baby SM; Lozynska O; Krag TO; Jensen CJ; Frödin M; Khurana TS
FEBS Lett; 2007 Sep; 581(22):4153-8. PubMed ID: 17692845
[TBL] [Abstract][Full Text] [Related]
2. Ets-2 repressor factor silences extrasynaptic utrophin by N-box mediated repression in skeletal muscle.
Perkins KJ; Basu U; Budak MT; Ketterer C; Baby SM; Lozynska O; Lunde JA; Jasmin BJ; Rubinstein NA; Khurana TS
Mol Biol Cell; 2007 Aug; 18(8):2864-72. PubMed ID: 17507653
[TBL] [Abstract][Full Text] [Related]
3. Heregulin ameliorates the dystrophic phenotype in mdx mice.
Krag TO; Bogdanovich S; Jensen CJ; Fischer MD; Hansen-Schwartz J; Javazon EH; Flake AW; Edvinsson L; Khurana TS
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13856-60. PubMed ID: 15365169
[TBL] [Abstract][Full Text] [Related]
4. Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3.
Vicent GP; Ballaré C; Nacht AS; Clausell J; Subtil-Rodríguez A; Quiles I; Jordan A; Beato M
Mol Cell; 2006 Nov; 24(3):367-81. PubMed ID: 17081988
[TBL] [Abstract][Full Text] [Related]
5. Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein alpha/beta.
Khurana TS; Rosmarin AG; Shang J; Krag TO; Das S; Gammeltoft S
Mol Biol Cell; 1999 Jun; 10(6):2075-86. PubMed ID: 10359616
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of transcription factor promoter regions by low-dose genistein through mitogen-activated protein kinase and mitogen-and-stress activated kinase 1 nongenomic signaling.
Yu L; Ham K; Gao X; Castro L; Yan Y; Kissling GE; Tucker CJ; Flagler N; Dong R; Archer TK; Dixon D
Cell Commun Signal; 2016 Aug; 14(1):18. PubMed ID: 27582276
[TBL] [Abstract][Full Text] [Related]
7. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine.
Takahashi J; Itoh Y; Fujimori K; Imamura M; Wakayama Y; Miyagoe-Suzuki Y; Takeda S
J Gene Med; 2005 Feb; 7(2):237-48. PubMed ID: 15538725
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of utrophin-A and -B promoters in the central nervous system (CNS) of normal and dystrophic mdx mice.
Baby SM; Bogdanovich S; Willmann G; Basu U; Lozynska O; Khurana TS
Brain Pathol; 2010 Mar; 20(2):323-42. PubMed ID: 19486009
[TBL] [Abstract][Full Text] [Related]
9. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
[TBL] [Abstract][Full Text] [Related]
10. Sp1 and the ets-related transcription factor complex GABP alpha/beta functionally cooperate to activate the utrophin promoter.
Gyrd-Hansen M; Krag TO; Rosmarin AG; Khurana TS
J Neurol Sci; 2002 May; 197(1-2):27-35. PubMed ID: 11997063
[TBL] [Abstract][Full Text] [Related]
11. Translational regulation of utrophin by miRNAs.
Basu U; Lozynska O; Moorwood C; Patel G; Wilton SD; Khurana TS
PLoS One; 2011; 6(12):e29376. PubMed ID: 22216264
[TBL] [Abstract][Full Text] [Related]
12. Utrophin is a calpain substrate in muscle cells.
Courdier-Fruh I; Briguet A
Muscle Nerve; 2006 Jun; 33(6):753-9. PubMed ID: 16598790
[TBL] [Abstract][Full Text] [Related]
13. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
Miura P; Jasmin BJ
Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393
[TBL] [Abstract][Full Text] [Related]
14. Promoter chromatin remodeling of immediate-early genes is mediated through H3 phosphorylation at either serine 28 or 10 by the MSK1 multi-protein complex.
Drobic B; Pérez-Cadahía B; Yu J; Kung SK; Davie JR
Nucleic Acids Res; 2010 Jun; 38(10):3196-208. PubMed ID: 20129940
[TBL] [Abstract][Full Text] [Related]
15. Duchenne muscular dystrophy drug discovery - the application of utrophin promoter activation screening.
Moorwood C; Khurana TS
Expert Opin Drug Discov; 2013 May; 8(5):569-81. PubMed ID: 23473647
[TBL] [Abstract][Full Text] [Related]
16. Utrophin upregulation in Duchenne muscular dystrophy.
Hirst RC; McCullagh KJ; Davies KE
Acta Myol; 2005 Dec; 24(3):209-16. PubMed ID: 16629055
[TBL] [Abstract][Full Text] [Related]
17. Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening.
Moorwood C; Lozynska O; Suri N; Napper AD; Diamond SL; Khurana TS
PLoS One; 2011; 6(10):e26169. PubMed ID: 22028826
[TBL] [Abstract][Full Text] [Related]
18. Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein.
Gramolini AO; Angus LM; Schaeffer L; Burton EA; Tinsley JM; Davies KE; Changeux JP; Jasmin BJ
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3223-7. PubMed ID: 10077665
[TBL] [Abstract][Full Text] [Related]
19. UtroUp is a novel six zinc finger artificial transcription factor that recognises 18 base pairs of the utrophin promoter and efficiently drives utrophin upregulation.
Onori A; Pisani C; Strimpakos G; Monaco L; Mattei E; Passananti C; Corbi N
BMC Mol Biol; 2013 Jan; 14():3. PubMed ID: 23363418
[TBL] [Abstract][Full Text] [Related]
20. The GTPase RhoA increases utrophin expression and stability, as well as its localization at the plasma membrane.
Bonet-Kerrache A; Fortier M; Comunale F; Gauthier-Rouvière C
Biochem J; 2005 Oct; 391(Pt 2):261-8. PubMed ID: 15963030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
